Table 1.

Experiences with selection and deselection of Nordic trial sites during site selection^a

Site-related quality	Survey question	Response
		Yes (%)	No (%)
Experience in conducting clinical trials / Interest and commitment	1. Have you experienced that your company selected/recommended an inexperienced trial site in favor of an experienced trial site during site selection due to a higher level of interest and commitment?	52	48
Interest and commitment	2. Have you experienced that your company selected/recommended a trial site unknown to your company in favor of a well-known trial site due to a higher level of interest and commitment?	57	43
Timely patient recruitment / Key opinion leader	3. Have you experienced that your company selected/recommended a trial site despite an insufficient recruitment in prior trials, because a key opinion leader was associated with the site?	63	37
Timely patient recruitment	4. Have you experienced that your company deselected/did not recommend a trial site that delivered a timely patient recruitment in prior trials, because your company found it difficult to cooperate with the site in those prior trials?	53	47
Costs at the site	5. Have you experienced that the trial sites selected by the affiliate(s) were not approved by the headquarters because the costs of running the trial at the trial sites were too high?b	37	63
Costs at the site	6. Have you experienced that your company did not recommend trial sites to a sponsor because the costs of running the trial at the trial sites were too high?c	25	75

^a Respondents (n = 83) were asked about their experiences with site selection at the company they worked for. The words selected and deselected applied to biopharmaceutical respondents whereas the words recommended and did not recommend applied to clinical research organization respondents

^b This question only applied to biopharmaceutical respondents (n = 43)

^c This question only applied to clinical research organization respondents (n = 40)